Time to Humanize

Human disease models are crucial for addressing the complexities of treating neurodegenerative disorders. SCANME provides researchers with access to biologically relevant human cell types and unrivalled scalability. Discover what sets SCANME apart in this video...

Leverage the features of SCANME

Customize SCANME's full suite of capabilities to meet your research needs. From target validation and hypothesis testing in human cell models to deepening SAR understanding, uncovering mechanisms of action, and exploring novel biological pathways.

 

 

F-Human-Derived Microglia
F-High Content Imaging
F-Workflow Automation
F-Miniaturization
*Powered by axoCells™ - the leading choice for functionally relevant human iPSC-derived cells (or customer's preferred source)

Why SCANME for your drug discovery program?

SCANME redefines the use of humanized in vitro assays for drug discovery. Unlock its potential, today.

B-Access
B-Scale Up-1
B- Customize
B-Increase

Delivering for our customers - a proven track record

  • 48 pre-clinical candidates delivered
  • 27 already progressed to clinical trials (>50%)
  • Sygnature Discovery co-inventors named on >170 client patent applications
Performance graph only (with atom filigrane)-1

Ask us about the benefits of SCANME

Talk to an expert